Roche Trims Four Early Assets as Q1 Sales Slip 6% on Currency, COVID Headwinds

Roche released its first-quarter 2024 earnings results on Wednesday posting a 6% decline in sales compared to the same prior year period, as the company continued to be weighed down by weak demand for COVID-19 products and currency headwinds while narrowly beating analysts’ expectations.